Kevin G. Mark

1.6k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Kevin G. Mark is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Kevin G. Mark has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Cell Biology and 4 papers in Oncology. Recurrent topics in Kevin G. Mark's work include Ubiquitin and proteasome pathways (7 papers), Microtubule and mitosis dynamics (3 papers) and Protein Degradation and Inhibitors (3 papers). Kevin G. Mark is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Microtubule and mitosis dynamics (3 papers) and Protein Degradation and Inhibitors (3 papers). Kevin G. Mark collaborates with scholars based in United States, Switzerland and Germany. Kevin G. Mark's co-authors include Michael Rapé, William L. Gerald, Jacqueline Bromberg, Kenneth Leslie, Darren R. Veach, Noriko Motoi, William G. Bornmann, Sizhi Paul Gao, William D. Travis and Bayard Clarkson and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Kevin G. Mark

15 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

2007 535 citations Sizhi Paul Gao, Kevin G. Mark et al. Journal of Clinical Investigation profile →

Peers

Kevin G. Mark

MB

ONCOL

IMMUN

PRM

CR

Jiexi Li United States

Paul M. Grandgenett United States

Luis E. Arias‐Romero Mexico

Rachelle Kosoff United States

Rebecca Smith United States

Kavitha Gowrishankar Australia

Takayuki Kawakami Japan

Sai-Wen Tang United States

Joseph H. Jeong United States

Sayan Chakraborty United States

Jiexi Li United States

Kevin G. Mark

631 ×1.0

MB

318 ×0.7

ONCOL

260 ×1.3

IMMUN

128 ×0.8

PRM

238 ×1.5

CR

Citations per year, relative to Kevin G. Mark Kevin G. Mark (= 1×) peers Jiexi Li

Countries citing papers authored by Kevin G. Mark

Since Specialization

Citations

This map shows the geographic impact of Kevin G. Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin G. Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin G. Mark more than expected).

Fields of papers citing papers by Kevin G. Mark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin G. Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin G. Mark. The network helps show where Kevin G. Mark may publish in the future.

Co-authorship network of co-authors of Kevin G. Mark

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin G. Mark. A scholar is included among the top collaborators of Kevin G. Mark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin G. Mark. Kevin G. Mark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Liu, Shixuan, Miriam B. Ginzberg, Nish Patel, et al.. (2025). Oversized cells activate global proteasome-mediated protein degradation to maintain cell size homeostasis. eLife. 14.

2.

Mark, Kevin G., Jacob D. Aguirre, Danielle M. Garshott, et al.. (2023). Orphan quality control shapes network dynamics and gene expression. Cell. 186(16). 3460–3475.e23. 30 indexed citations

3.

Ye, Mengchen, et al.. (2022). Assembly and function of branched ubiquitin chains. Trends in Biochemical Sciences. 47(9). 759–771. 66 indexed citations

4.

Mark, Kevin G. & Michael Rapé. (2021). Ubiquitin‐dependent regulation of transcription in development and disease. EMBO Reports. 22(4). e51078–e51078. 22 indexed citations

5.

Oh, Eugene, Kevin G. Mark, Edmond R. Watson, et al.. (2020). Gene expression and cell identity controlled by anaphase-promoting complex. Nature. 579(7797). 136–140. 67 indexed citations

6.

Engström, Patrik, Thomas Burke, Gabriel Mitchell, et al.. (2019). Evasion of autophagy mediated by Rickettsia surface protein OmpB is critical for virulence. Nature Microbiology. 4(12). 2538–2551. 53 indexed citations

7.

Cappell, Steven D., Kevin G. Mark, Damien Garbett, et al.. (2018). EMI1 switches from being a substrate to an inhibitor of APC/CCDH1 to start the cell cycle. Nature. 558(7709). 313–317. 103 indexed citations

8.

Mark, Kevin G., et al.. (2016). Isolation of ubiquitinated substrates by tandem affinity purification of E3 ligase–polyubiquitin-binding domain fusions (ligase traps). Nature Protocols. 11(2). 291–301. 30 indexed citations

9.

Mark, Kevin G., et al.. (2015). Ndd1 Turnover by SCFGrr1 Is Inhibited by the DNA Damage Checkpoint in Saccharomyces cerevisiae. PLoS Genetics. 11(4). e1005162–e1005162. 6 indexed citations

10.

Mark, Kevin G., et al.. (2015). Prb1 Protease Activity Is Required for Its Recognition by the F-Box Protein Saf1. Biochemistry. 54(29). 4423–4426. 2 indexed citations

11.

Mark, Kevin G., Marco Simonetta, Alessio Maiolica, Charles A. Seller, & David P. Toczyski. (2014). Ubiquitin Ligase Trapping Identifies an SCFSaf1 Pathway Targeting Unprocessed Vacuolar/Lysosomal Proteins. Molecular Cell. 53(1). 148–161. 41 indexed citations

12.

Hett, Erik C., Kevin G. Mark, Tomohiko Kawate, et al.. (2013). Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis. Nature Chemical Biology. 9(6). 398–405. 68 indexed citations

13.

Hett, Erik C., Kevin G. Mark, Nicole M. Chumbler, et al.. (2013). Identification of Novel Host-Targeted Compounds That Protect from Anthrax Lethal Toxin-Induced Cell Death. ACS Chemical Biology. 8(4). 812–822. 17 indexed citations

14.

Hett, Erik C., et al.. (2013). CCT chaperonin complex is required for efficient delivery of anthrax toxin into the cytosol of host cells. Proceedings of the National Academy of Sciences. 110(24). 9932–9937. 11 indexed citations

15.

Azare, Janeen, Ashley S. Doane, Kenneth Leslie, et al.. (2011). Stat3 Mediates Expression of Autotaxin in Breast Cancer. PLoS ONE. 6(11). e27851–e27851. 65 indexed citations

16.

Gao, Sizhi Paul, Kevin G. Mark, Kenneth Leslie, et al.. (2007). Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. Journal of Clinical Investigation. 117(12). 3846–3856. 535 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact